The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19567524.
- Also identified by DOI 10.1210/jc.2009-0544.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The prenatal antecedents of polycystic ovary syndrome (PCOS) are not known, but prenatal androgen exposure is thought to contribute. This has not previously been investigated in large prospective studies of normal human pregnancy. The aim of the study was to establish the prospective relationship between early life androgen exposure and PCOS in adolescence. A prospective cohort study was conducted in the general community. A total of 2900 pregnant women were recruited at 18 wk gestation. Prenatal androgen exposure was measured from maternal blood samples (at 18 and 34-36 wk) and umbilical cord blood. Timed (d 2-5 menstrual cycle) blood samples were collected, clinical hyperandrogenism was assessed, and transabdominal ultrasound examination of ovarian morphology was performed in 244 unselected girls from the Raine cohort aged 14-17 yr. We examined the relationship between early life androgen exposure and PCOS in adolescence. We did not observe a statistically significant relationship between early life androgen exposure and PCOS in adolescence. This is the first prospective study to evaluate the relationship between prenatal androgen exposure and PCOS in adolescence in normal pregnancy. Our findings do not support the hypothesis that maternal androgens, within the normal range for pregnancy, directly program PCOS in the offspring.
Medical subject headings
- Androgens
- Fetal Blood
- Mothers
- Polycystic Ovary Syndrome
- Prenatal Exposure Delayed Effects